TOKYO -- Drugmakers from Japan, the U.S. and Europe have announced a more than $1 billion fund to invest in startups developing treatments for antibiotic-resistant infections.
Pharmaceuticals
Japan and Western drugmakers launch $1bn fund against superbugs
Takeda, Glaxo and Amgen among 23 names uniting to fight antibiotic resistance
A magnified image of methicillin-resistant Staphylococcus aureus bacteria: drug-resistant diseases kill about 700,000 people a year across the world. © Reuters
Read Next
Latest on Pharmaceuticals
